Teprotumumab — Drug Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

1 Recruiting

1 Completed trials

1 Sponsors

5 Countries

Phase III

Phase III/IV

Phase III: 1 Phase III/IV: 1

Sponsors using this IMP

2 total

A trial to investigate teprotumumab mg/ml subcutaneous administration compared with placebo in male and female adult participants with moder… Recruiting

2024-515702-63-00 Phase III 5 countries Horizon Therapeutics USA Inc.
N/A Ended

2024-515090-96-00 Phase III/IV 4 countries Horizon Therapeutics USA Inc.

Showing 1–2 of 2 trials